Tech Company Financing Transactions
BC Platforms Funding Round
BC Platforms, operating out of Boston, secured $9 million from Debiopharm Diagnostics and private investors.
Transaction Overview
Company Name
Announced On
5/10/2017
Transaction Type
Venture Equity
Amount
$9,000,000
Round
Undisclosed
Investors
Debiopharm Diagnostics (Lead Investor) (Tanja Dowe)
Proceeds Purpose
BC Platforms will use the funds to launch new technologies in 2017 integrating complex clinical and genomic data in order to deliver precision medicine and clinical patient benefits, as well as to grow its existing genomic data management software business worldwide.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
51 Melcher St.
Boston, MA 02210
USA
Boston, MA 02210
USA
Phone
Website
Email Address
Overview
BC Platforms is a world leader in providing powerful genomic data management solutions to address some of the biggest healthcare challenges today by leveraging the convergence of genomics and healthcare information technologies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tero Silvola
Chief Financial Officer
Anna Wozniak
Chief Operating Officer
Niko Hurskainen
Co-Founder
Timo Kanninen
VP - Sales
Nino da Silva
Browse more venture capital transactions:
Prev: 5/10/2017: Edico Genome venture capital transaction
Next: 5/10/2017: Finxact venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to record all VC transactions involving tech companies. VC investment data records on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs